Beneficial Ownership Report · SCHEDULE 13G
Indivior Pharmaceuticals, Inc.
INDVNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13G
primary_doc.xml
Subject company
- Company
- Indivior Pharmaceuticals, Inc.
- Company CIK
- 0001625297
- Street
- 10710 Midlothian Turnpike, Suite 125
- City
- North Chesterfield
- State / country code
- VA
- Postal code
- 23235
Statement details
- Security class
- Common Stock, par value $0.001 per share
- Event date
- 09/23/2026
- Rule designation
- Rule 13d-1(c)
Reporting person 1
- Name
- Millennium Management LLC
- Citizenship / organization
- DE
- Reporting person type
- OO
- Aggregate amount owned
- 6,343,651.00
- Percent of class
- 5.4
- Sole voting power
- 0.00
- Shared voting power
- 6,343,651.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 6,343,651.00
- Aggregate excludes certain shares
- N
Reporting person 2
- Name
- Millennium Group Management LLC
- Citizenship / organization
- DE
- Reporting person type
- OO
- Aggregate amount owned
- 6,343,651.00
- Percent of class
- 5.4
- Sole voting power
- 0.00
- Shared voting power
- 6,343,651.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 6,343,651.00
- Aggregate excludes certain shares
- N
Reporting person 3
- Name
- Israel A. Englander
- Citizenship / organization
- X1
- Reporting person type
- IN
- Aggregate amount owned
- 6,343,651.00
- Percent of class
- 5.4
- Sole voting power
- 0.00
- Shared voting power
- 6,343,651.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 6,343,651.00
- Aggregate excludes certain shares
- N
Item 1
Issuer
Indivior Pharmaceuticals, Inc.
Principal executive office address
10710 Midlothian Turnpike, Suite 125, North Chesterfield, Virginia 23235
Item 2
Citizenship
Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
Filing person
Millennium Management LLC Millennium Group Management LLC Israel A. Englander
Principal business or residence address
Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
Item 3
Not applicable indication
Y
Item 4
Percent of class
See response to Item 11 on each cover page.
Amount beneficially owned
See response to Item 9 on each cover page.
Sole voting power
See response to Item 5 on each cover page.
Shared voting power
See response to Item 6 on each cover page.
Sole dispositive power
See response to Item 7 on each cover page.
Shared dispositive power
See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5
Not applicable indication
Y
Item 6
Not applicable indication
Y
Item 7
Not applicable indication
Y
Item 8
Not applicable indication
Y
Item 9
Not applicable indication
Y
Item 10
Not applicable indication
N
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Exhibits
Exhibit I: Joint Filing Agreement, dated as of September 29, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.
Signature 1
- Reporting person
- Millennium Management LLC
- Signed
- /s/ Gil Raviv
- Title
- Gil Raviv, Global General Counsel
- Date
- 09/29/2026
Signature 2
- Reporting person
- Millennium Group Management LLC
- Signed
- /s/ Gil Raviv
- Title
- Gil Raviv, Global General Counsel
- Date
- 09/29/2026
Signature 3
- Reporting person
- Israel A. Englander
- Signed
- /s/ Israel A. Englander
- Title
- Israel A. Englander
- Date
- 09/29/2026
Filed exhibits
- EXHIBIT 1 ↗tm2626708d1_ex-1.htm
Company context
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine, developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together - with science, people living with OUD, public health champions, and communities - we are powering recovery and renewing hope. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.